Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer

Lung. 2017 Oct;195(5):619-626. doi: 10.1007/s00408-017-0025-2. Epub 2017 Jun 20.

Abstract

Purpose: Older patients with lung cancer are a heterogeneous population making treatment decisions complex. This study aims to evaluate the value of geriatric assessment (GA) as well as the evolution of functional status (FS) in older patients with lung cancer, and to identify predictors associated with functional decline and overall survival (OS).

Methods: At baseline, GA was performed in patients ≥70 years with newly diagnosed lung cancer. FS measured by activities of daily living (ADL) and instrumental activities of daily living (IADL) was reassessed at follow-up to define functional decline and OS was collected. Predictors for functional decline and OS were determined.

Results: Two hundred and forty-five patients were included in this study. At baseline, GA deficiencies were present in all domains and ADL and IADL were impaired in 51 and 63% of patients, respectively. At follow-up, functional decline in ADL was observed in 23% and in IADL in 45% of patients. In multivariable analysis, radiotherapy was predictive for ADL decline. No other predictors for ADL or IADL decline were identified. Stage and baseline performance status were predictive for OS.

Conclusions: Older patients with lung cancer present with multiple deficiencies covering all geriatric domains. During treatment, functional decline is observed in almost half of the patients. None of the specific domains of the GA were predictive for functional decline or survival, probably because of the high impact of the aggressiveness of this tumor type leading to a poor prognosis.

Keywords: Functional decline; Geriatric assessment; Lung cancer; Older.

MeSH terms

  • Activities of Daily Living*
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Belgium
  • Carcinoma, Non-Small-Cell Lung / complications
  • Carcinoma, Non-Small-Cell Lung / physiopathology*
  • Carcinoma, Non-Small-Cell Lung / therapy
  • Carcinoma, Squamous Cell / complications
  • Carcinoma, Squamous Cell / physiopathology*
  • Carcinoma, Squamous Cell / therapy
  • Clinical Decision-Making
  • Cognition
  • Comorbidity
  • Fatigue / etiology
  • Fatigue / physiopathology
  • Female
  • Follow-Up Studies
  • Geriatric Assessment*
  • Humans
  • Logistic Models
  • Lung / surgery
  • Lung Neoplasms / complications
  • Lung Neoplasms / physiopathology*
  • Lung Neoplasms / therapy
  • Male
  • Mental Status Schedule
  • Multivariate Analysis
  • Nutritional Status
  • Polypharmacy
  • Prognosis
  • Radiotherapy
  • Residence Characteristics
  • Risk Factors
  • Small Cell Lung Carcinoma / complications
  • Small Cell Lung Carcinoma / physiopathology*
  • Small Cell Lung Carcinoma / therapy
  • Surgical Procedures, Operative
  • Survival Rate

Substances

  • Antineoplastic Agents